410 related articles for article (PubMed ID: 12761811)
1. Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs.
Tronde A; Nordén B; Marchner H; Wendel AK; Lennernäs H; Bengtsson UH
J Pharm Sci; 2003 Jun; 92(6):1216-33. PubMed ID: 12761811
[TBL] [Abstract][Full Text] [Related]
2. Drug absorption from the isolated perfused rat lung--correlations with drug physicochemical properties and epithelial permeability.
Tronde A; Nordén B; Jeppsson AB; Brunmark P; Nilsson E; Lennernäs H; Bengtsson UH
J Drug Target; 2003 Jan; 11(1):61-74. PubMed ID: 12852442
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary absorption - estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysis.
Eriksson J; Sjögren E; Thörn H; Rubin K; Bäckman P; Lennernäs H
Eur J Pharm Biopharm; 2018 Mar; 124():1-12. PubMed ID: 29191716
[TBL] [Abstract][Full Text] [Related]
4. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
5. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion.
Hao H; Wang G; Cui N; Li J; Xie L; Ding Z
Planta Med; 2006 Nov; 72(14):1311-7. PubMed ID: 17024606
[TBL] [Abstract][Full Text] [Related]
7. Visualized absorption of anti-atherosclerotic dipeptide, Trp-His, in Sprague-Dawley rats by LC-MS and MALDI-MS imaging analyses.
Tanaka M; Hong SM; Akiyama S; Hu QQ; Matsui T
Mol Nutr Food Res; 2015 Aug; 59(8):1541-9. PubMed ID: 25808120
[TBL] [Abstract][Full Text] [Related]
8. Species comparison of drug absorption from the lung after aerosol inhalation or intratracheal injection.
Schanker LS; Mitchell EW; Brown RA
Drug Metab Dispos; 1986; 14(1):79-88. PubMed ID: 2868870
[TBL] [Abstract][Full Text] [Related]
9. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
Varma MV; Sateesh K; Panchagnula R
Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of caffeic acid in rats and its absorption properties in the Caco-2 cell model.
Wang SJ; Zeng J; Yang BK; Zhong YM
Pharm Biol; 2014 Sep; 52(9):1150-7. PubMed ID: 24635458
[TBL] [Abstract][Full Text] [Related]
12. Targeting intestinal transporters for optimizing oral drug absorption.
Varma MV; Ambler CM; Ullah M; Rotter CJ; Sun H; Litchfield J; Fenner KS; El-Kattan AF
Curr Drug Metab; 2010 Nov; 11(9):730-42. PubMed ID: 21189135
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of positively charged liposaccharide derivatives as oral absorption enhancers for the delivery of anionic drugs.
Bergeon JA; Ziora ZM; Abdelrahim AS; Pernevi NU; Moss AR; Toth I
J Pharm Sci; 2010 May; 99(5):2333-42. PubMed ID: 19911429
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of oral absorption of panaxnotoginseng saponins].
Han M; Han LM; Wang QS; Bai ZH; Fang XL
Yao Xue Xue Bao; 2006 Jun; 41(6):498-505. PubMed ID: 16927822
[TBL] [Abstract][Full Text] [Related]
15. Physiological models are good tools to predict rat bioavailability of EF5154 prodrugs from in vitro intestinal parameters.
Nomoto M; Tatebayashi T; Morita J; Suzuki H; Aizawa K; Kurosawa T; Komiya I
J Pharm Sci; 2009 Apr; 98(4):1532-44. PubMed ID: 18683862
[TBL] [Abstract][Full Text] [Related]
16. Estimation of the extent of oral absorption in animals from oral and intravenous pharmacokinetic data in drug discovery.
Nomeir AA; Morrison R; Prelusky D; Korfmacher W; Broske L; Hesk D; McNamara P; Mei H
J Pharm Sci; 2009 Nov; 98(11):4027-38. PubMed ID: 19226636
[TBL] [Abstract][Full Text] [Related]
17. The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.
Liu T; Chang LJ; Uss A; Chu I; Morrison RA; Wang L; Prelusky D; Cheng KC; Li C
J Pharm Biomed Anal; 2010 Apr; 51(5):1069-77. PubMed ID: 20036089
[TBL] [Abstract][Full Text] [Related]
18. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia.
Stephens RH; O'Neill CA; Warhurst A; Carlson GL; Rowland M; Warhurst G
J Pharmacol Exp Ther; 2001 Feb; 296(2):584-91. PubMed ID: 11160647
[TBL] [Abstract][Full Text] [Related]
19. Regional differences in bioavailability of an opioid tetrapeptide in vivo in rats after administration to the respiratory tract.
Krondahl E; Tronde A; Eirefelt S; Forsmo-Bruce H; Ekström G; Bengtsson UH; Lennernäs H
Peptides; 2002 Mar; 23(3):479-88. PubMed ID: 11835997
[TBL] [Abstract][Full Text] [Related]
20. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A
Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
